These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 20536988

  • 1. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC, Fischer K, Gouw SC, Van Dijk K, Mauser-Bunschoten EP.
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [Abstract] [Full Text] [Related]

  • 2. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM, RITS-FITNHES Study Group.
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [Abstract] [Full Text] [Related]

  • 3. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A, Kavakli K, Baytan B, Kazanci E, Sayli T, Oren H, Celkan T, Gursel T.
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [Abstract] [Full Text] [Related]

  • 4. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
    Rivard GE, Rothschild C, Toll T, Achilles K.
    Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
    [Abstract] [Full Text] [Related]

  • 5. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
    Lin PC, Liao YM, Tsai SP, Chang TT.
    Pediatr Blood Cancer; 2011 Dec 01; 57(6):1029-33. PubMed ID: 21793191
    [Abstract] [Full Text] [Related]

  • 6. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W, Escuriola Ettingshausen C, Vdovin V, Zozulya N, Plyushch O, Svirin P, Andreeva T, Bubanská E, Campos M, Benedik-Dolničar M, Jiménez-Yuste V, Kitanovski L, Klukowska A, Momot A, Osmulskaya N, Prieto M, Šalek SZ, Velasco F, Pavlova A, Oldenburg J, Knaub S, Jansen M, Belyanskaya L, Walter O, ObsITI study group, ObsITI committee.
    Haemophilia; 2016 Jan 01; 22(1):87-95. PubMed ID: 26202305
    [Abstract] [Full Text] [Related]

  • 7. Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.
    Valentino LA, Recht M, Dipaola J, Shapiro AD, Pipe SW, Ewing N, Urgo J, Bullock T, Simmons M, Deguzman C.
    Haemophilia; 2009 May 01; 15(3):718-26. PubMed ID: 19298383
    [Abstract] [Full Text] [Related]

  • 8. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
    Nakar C, Manco-Johnson MJ, Lail A, Donfield S, Maahs J, Chong Y, Blades T, Shapiro A.
    Haemophilia; 2015 May 01; 21(3):365-373. PubMed ID: 25581638
    [Abstract] [Full Text] [Related]

  • 9. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA, Saint-Remy JM, Jacquemin M, Benhida A, DiMichele DM.
    Haemophilia; 2008 Mar 01; 14(2):295-302. PubMed ID: 18081826
    [Abstract] [Full Text] [Related]

  • 10. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L, Pitlik E.
    Haematologica; 2000 Oct 01; 85(10 Suppl):64-8. PubMed ID: 11187874
    [Abstract] [Full Text] [Related]

  • 11. The long-term course of factor VIII inhibitors in patients with congenital haemophilia A without immune tolerance induction.
    Caram C, de Souza RG, de Sousa JC, Araújo Pereira T, do Amaral Cerqueira AM, van der Bom JG, Rezende SM.
    Thromb Haemost; 2011 Jan 01; 105(1):59-65. PubMed ID: 21057702
    [Abstract] [Full Text] [Related]

  • 12. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
    Oldenburg J, Jiménez-Yuste V, Peiró-Jordán R, Aledort LM, Santagostino E.
    Haemophilia; 2014 Jan 01; 20(1):83-91. PubMed ID: 24354480
    [Abstract] [Full Text] [Related]

  • 13. The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?
    Ettingshausen CE, Kreuz W.
    Haemophilia; 2013 Jan 01; 19 Suppl 1():12-7. PubMed ID: 23278995
    [Abstract] [Full Text] [Related]

  • 14. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun 01; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 15. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
    Rothschild C, D'Oiron R, Borel-Derlon A, Gruel Y, Navarro R, Negrier C.
    Haemophilia; 2013 Mar 01; 19(2):281-6. PubMed ID: 23038998
    [Abstract] [Full Text] [Related]

  • 16. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
    Unuvar A, Warrier I, Lusher JM.
    Haemophilia; 2000 May 01; 6(3):150-7. PubMed ID: 10792472
    [Abstract] [Full Text] [Related]

  • 17. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M, Kumari M, Shamsi T, Naz A, Farzana T.
    J Coll Physicians Surg Pak; 2012 May 01; 22(5):289-93. PubMed ID: 22538032
    [Abstract] [Full Text] [Related]

  • 18. Hemophilia treatment. Immune tolerance induction: prospective clinical trials.
    Hay CR.
    Haematologica; 2000 Oct 01; 85(10 Suppl):52-5; discussion 55-6. PubMed ID: 11187872
    [Abstract] [Full Text] [Related]

  • 19. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
    van Helden PM, van den Berg HM, Gouw SC, Kaijen PH, Zuurveld MG, Mauser-Bunschoten EP, Aalberse RC, Vidarsson G, Voorberg J.
    Br J Haematol; 2008 Aug 01; 142(4):644-52. PubMed ID: 18510679
    [Abstract] [Full Text] [Related]

  • 20. How I treat inhibitors in haemophilia.
    Makris M, Hay CR, Gringeri A, D'Oiron R.
    Haemophilia; 2012 Jul 01; 18 Suppl 4():48-53. PubMed ID: 22726083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.